MARKET

MDWD

MDWD

Mediwound
NASDAQ
15.05
-0.66
-4.20%
Closed 16:10 03/27 EDT
OPEN
15.72
PREV CLOSE
15.71
HIGH
16.12
LOW
14.94
VOLUME
123.20K
TURNOVER
0
52 WEEK HIGH
22.51
52 WEEK LOW
14.14
MARKET CAP
193.33M
P/E (TTM)
-7.1701
1D
5D
1M
3M
1Y
5Y
1D
MediWound files Form 3 initial beneficial ownership statement; director Vickie Rae Driver reports 1,910 ordinary shares
Reuters · 4d ago
Weekly Report: what happened at MDWD last week (0316-0320)?
Weekly Report · 6d ago
MediWound Ltd. files Form 3 initial beneficial ownership statement for CFO Hana Luxenburg Kalfon
Reuters · 03/18 21:35
MediWound Ltd. files Form 3 initial beneficial ownership statement for Chief Medical Officer Ety Klinger
Reuters · 03/18 21:34
MediWound Ltd. Director David Morton Fox Files Initial Beneficial Ownership Statement
Reuters · 03/18 21:32
MediWound VP Clinical & Reg. Affairs Ben Yaakov Aya files Form 3 initial beneficial ownership statement
Reuters · 03/18 21:30
MediWound Ltd. EVP, GC and Corporate Secretary Yaron Meyer files Form 3 initial beneficial ownership statement
Reuters · 03/18 21:28
MediWound Ltd. Director Stephen T. Wills Files Initial Beneficial Ownership Statement
Reuters · 03/18 21:25
More
About MDWD
Mediwound Ltd is an Israel-based biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic solutions for tissue repair and regeneration. Company's portfolio is focused on next-generation protein-based therapies for burn and wound care and tissue repair and includes products such as, NexoBrid, a concentrate of proteolytic enzymes enriched in bromelain, which is an easy to use, topically-applied product that removes eschar in four hours without harming the surrounding healthy tissues.; EscharEx biological drug candidate for the debridement of chronic and other hard-to-heal wounds; MW005 a topically applied biological drug candidate for the treatment of non-melanoma skin cancers, based on the same API of NexoBrid and EscharEx products, a concentrate of proteolytic enzymes enriched in bromelain.

Webull offers Mediwound Ltd stock information, including NASDAQ: MDWD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MDWD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MDWD stock methods without spending real money on the virtual paper trading platform.